Metraipolis › archive › dc_b1bc8ecce048

Initial Dose Tarlatamab-Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report — Europe PMC PMID:42371484

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42371484
DOI
10.1002/rcr2.70667
License (as archived)
solo-consultazione
Archived
2026-10-18T15:42:43.405Z
SHA-256 of the archived text
cbc5eca84528436fbef1e2f557d82e2728a12939b4fccbde1a71d2bd014d1327
Stable URL of this page
https://metraipolis.com/documento/dc_b1bc8ecce048

How to cite

Initial Dose Tarlatamab-Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report — Europe PMC PMID:42371484 — Europe PMC (en), https://europepmc.org/article/MED/42371484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b1bc8ecce048 (Metraipolis archive dc_b1bc8ecce048, sha256 cbc5eca84528436fbef1e2f557d82e2728a12939b4fccbde1a71d2bd014d1327)
BibTeX
@misc{dcb1bc8ecce048,
  title = {Initial Dose Tarlatamab-Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report — Europe PMC PMID:42371484},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42371484},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b1bc8ecce048; sha256 cbc5eca84528436fbef1e2f557d82e2728a12939b4fccbde1a71d2bd014d1327},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42371484. Agents can read the archived copy with the MCP tool read_document.